Preventive Study among COVID 19 frontline warriors and their families

A prospective non-randomized open label interventional study on the effect of AYURAKSHA Immuno boosting Kit as a prophylactic measure among frontline COVID warriors and their family members

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027661

Enrollment

3000

Registered

2020-09-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ayuraksha Immunoboosting Kit: Chyavanprash (180gm) -1 teaspoon Once a day AYUSH Kwath (100mg) - 3 gm boiled in 150ml water filtered and consumed Samsamani vati (30gm) -2 tab bd with

Eligibility

Inclusion criteria

Inclusion criteria: Male or female participants above the age of 18 years to 70 years Police Officers, Media personnel, Health care workers; Sanitization workers, and their family members Participants who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study

Exclusion criteria

Exclusion criteria: Known cases Covid-19. Pregnant and Lactating females Known cases of uncontrolled Diabetes and Hypertension Participants having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening Participants having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc. Participants taking Steroid treatment and or any kind of immunosuppressive therapy Participants participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. Participants having a history of allergy to any medicine that is part of the Ayurvedic intervention. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in, and completion of the protocol

Design outcomes

Primary

Measure	Time frame
Assessment of occurrence of COVID-19 infection in frontline COVID warriors and their family membersTimepoint: Assessment Done at Baseline(Day 0) and at Day 30	—

Secondary

Measure	Time frame
Assessment of Improvement in general health parametersTimepoint: Before and after	—

Countries

India

Contacts

Public ContactDr Krishna Rao S

CCRAS,Under AYUSH

krdrkrishnarao@gmail.com

Outcome results